Kidney Impairment Articles & Analysis: Older
2 news found
The primary driver of their MRI contrast agent decisions is patient safety, and in particular the need to minimize the risk of Nephrogenic Systemic Fibrosis (NSF), a side-effect associated with the currently available gadolinium agents in patients with reduced kidney function – the target population for Orviglance. They were also concerned about allergies and gadolinium ...
Since its launch in China in 2018, it has benefited many Chinese patients, and has provided new treatment options for severely ill hospitalized patients, drug-resistant patients, and patients with liver and kidney impairment. Multiple controlled clinical trials and accumulated real-world data show that Aikening® has high efficacy and safety, with minimal drug ...